In this report, the Asia-Pacific Biologic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Biologic Drugs for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Biologic Drugs market competition by top manufacturers/players, with Biologic Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Biologic Drugs for each application, includin
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Asia-Pacific Biologic Drugs Market Report 2017
1 Biologic Drugs Overview
1.1 Product Overview and Scope of Biologic Drugs
1.2 Classification of Biologic Drugs by Product Category
1.2.1 Asia-Pacific Biologic Drugs Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific Biologic Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Humira
1.2.4 Remicade
1.2.5 Rituxan
1.2.6 Enbrel
1.2.7 Lantus
1.2.8 Avastin
1.2.9 Herceptin
1.2.10 Others
1.3 Asia-Pacific Biologic Drugs Market by Application/End Users
1.3.1 Asia-Pacific Biologic Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Diabetes
1.3.3 Inflammation
1.3.4 Auto-Immune Diseases
1.3.5 Blood Diseases
1.3.6 Cardiovascular Diseases
1.3.7 Others
1.4 Asia-Pacific Biologic Drugs Market by Region
1.4.1 Asia-Pacific Biologic Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Biologic Drugs (2012-2022)
1.5.1 Asia-Pacific Biologic Drugs Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific Biologic Drugs Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Biologic Drugs Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Biologic Drugs Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Biologic Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific Biologic Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Biologic Drugs (Volume and Value) by Type
2.2.1 Asia-Pacific Biologic Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific Biologic Drugs Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Biologic Drugs (Volume) by Application
2.4 Asia-Pacific Biologic Drugs (Volume and Value) by Region
2.4.1 Asia-Pacific Biologic Drugs Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific Biologic Drugs Revenue and Market Share by Region (2012-2017)

3 China Biologic Drugs (Volume, Value and Sales Price)
3.1 China Biologic Drugs Sales and Value (2012-2017)
3.1.1 China Biologic Drugs Sales Volume and Growth Rate (2012-2017)
3.1.2 China Biologic Drugs Revenue and Growth Rate (2012-2017)
3.1.3 China Biologic Drugs Sales Price Trend (2012-2017)
3.2 China Biologic Drugs Sales Volume and Market Share by Type
3.3 China Biologic Drugs Sales Volume and Market Share by Application

4 Japan Biologic Drugs (Volume, Value and Sales Price)
4.1 Japan Biologic Drugs Sales and Value (2012-2017)
4.1.1 Japan Biologic Drugs Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan Biologic Drugs Revenue and Growth Rate (2012-2017)
4.1.3 Japan Biologic Drugs Sales Price Trend (2012-2017)
4.2 Japan Biologic Drugs Sales Volume and Market Share by Type
4.3 Japan Biologic Drugs Sales Volume and Market Share by Application

5 South Korea Biologic Drugs (Volume, Value and Sales Price)
5.1 South Korea Biologic Drugs Sales and Value (2012-2017)
5.1.1 South Korea Biologic Drugs Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea Biologic Drugs Revenue and Growth Rate (2012-2017)
5.1.3 South Korea Biologic Drugs Sales Price Trend (2012-2017)
5.2 South Korea Biologic Drugs Sales Volume and Market Share by Type
5.3 South Korea Biologic Drugs Sales Volume and Market Share by Application

6 Taiwan Biologic Drugs (Volume, Value and Sales Price)
6.1 Taiwan Biologic Drugs Sales and Value (2012-2017)
6.1.1 Taiwan Biologic Drugs Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan Biologic Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan Biologic Drugs Sales Price Trend (2012-2017)
6.2 Taiwan Biologic Drugs Sales Volume and Market Share by Type
6.3 Taiwan Biologic Drugs Sales Volume and Market Share by Application

7 India Biologic Drugs (Volume, Value and Sales Price)
7.1 India Biologic Drugs Sales and Value (2012-2017)
7.1.1 India Biologic Drugs Sales Volume and Growth Rate (2012-2017)
7.1.2 India Biologic Drugs Revenue and Growth Rate (2012-2017)
7.1.3 India Biologic Drugs Sales Price Trend (2012-2017)
7.2 India Biologic Drugs Sales Volume and Market Share by Type
7.3 India Biologic Drugs Sales Volume and Market Share by Application

8 Southeast Asia Biologic Drugs (Volume, Value and Sales Price)
8.1 Southeast Asia Biologic Drugs Sales and Value (2012-2017)
8.1.1 Southeast Asia Biologic Drugs Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia Biologic Drugs Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia Biologic Drugs Sales Price Trend (2012-2017)
8.2 Southeast Asia Biologic Drugs Sales Volume and Market Share by Type
8.3 Southeast Asia Biologic Drugs Sales Volume and Market Share by Application

9 Australia Biologic Drugs (Volume, Value and Sales Price)
9.1 Australia Biologic Drugs Sales and Value (2012-2017)
9.1.1 Australia Biologic Drugs Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia Biologic Drugs Revenue and Growth Rate (2012-2017)
9.1.3 Australia Biologic Drugs Sales Price Trend (2012-2017)
9.2 Australia Biologic Drugs Sales Volume and Market Share by Type
9.3 Australia Biologic Drugs Sales Volume and Market Share by Application

10 Asia-Pacific Biologic Drugs Players/Suppliers Profiles and Sales Data
10.1 Roche
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Biologic Drugs Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Roche Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Abbott Laboratories
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Biologic Drugs Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Abbott Laboratories Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Johnson & Johnson
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Biologic Drugs Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Johnson & Johnson Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Merck & Co.
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Biologic Drugs Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Merck & Co. Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Pfizer
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Biologic Drugs Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Pfizer Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Amgen
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Biologic Drugs Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Amgen Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Sanofi
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Biologic Drugs Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Sanofi Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Novartis
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Biologic Drugs Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Novartis Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Eli Lilly
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Biologic Drugs Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Eli Lilly Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Amgen
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Biologic Drugs Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Amgen Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview

11 Biologic Drugs Manufacturing Cost Analysis
11.1 Biologic Drugs Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Biologic Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Biologic Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Biologic Drugs Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Biologic Drugs Market Forecast (2017-2022)
15.1 Asia-Pacific Biologic Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific Biologic Drugs Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific Biologic Drugs Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific Biologic Drugs Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Biologic Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific Biologic Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific Biologic Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China Biologic Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan Biologic Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea Biologic Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan Biologic Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India Biologic Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia Biologic Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia Biologic Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Biologic Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific Biologic Drugs Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific Biologic Drugs Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific Biologic Drugs Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Biologic Drugs Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer




List of Tables and Figures

Figure Product Picture of Biologic Drugs
Figure Asia-Pacific Biologic Drugs Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Biologic Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Humira Product Picture
Figure Remicade Product Picture
Figure Rituxan Product Picture
Figure Enbrel Product Picture
Figure Lantus Product Picture
Figure Avastin Product Picture
Figure Herceptin Product Picture
Figure Others Product Picture
Figure Asia-Pacific Biologic Drugs Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Biologic Drugs by Application in 2016
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Inflammation Examples
Table Key Downstream Customer in Inflammation
Figure Auto-Immune Diseases Examples
Table Key Downstream Customer in Auto-Immune Diseases
Figure Blood Diseases Examples
Table Key Downstream Customer in Blood Diseases
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Biologic Drugs Market Size (Million USD) by Region (2012-2022)
Figure China Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Biologic Drugs Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Biologic Drugs Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Biologic Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Biologic Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Biologic Drugs Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Biologic Drugs Sales Share by Players/Suppliers
Figure Asia-Pacific Biologic Drugs Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Biologic Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Biologic Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Biologic Drugs Revenue Share by Players
Figure 2017 Asia-Pacific Biologic Drugs Revenue Share by Players
Table Asia-Pacific Biologic Drugs Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Biologic Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Biologic Drugs by Type (2012-2017)
Figure Asia-Pacific Biologic Drugs Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Biologic Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Biologic Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biologic Drugs by Type (2012-2017)
Figure Asia-Pacific Biologic Drugs Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Biologic Drugs Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Biologic Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Biologic Drugs by Region (2012-2017)
Figure Asia-Pacific Biologic Drugs Sales Market Share by Region in 2016
Table Asia-Pacific Biologic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Biologic Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Biologic Drugs by Region (2012-2017)
Figure Asia-Pacific Biologic Drugs Revenue Market Share by Region in 2016
Table Asia-Pacific Biologic Drugs Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Biologic Drugs Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Biologic Drugs Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Biologic Drugs Sales Market Share by Application (2012-2017)
Figure China Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure China Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Biologic Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China Biologic Drugs Sales Volume (K Units) by Type (2012-2017)
Table China Biologic Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Biologic Drugs Sales Volume Market Share by Type in 2016
Table China Biologic Drugs Sales Volume (K Units) by Applications (2012-2017)
Table China Biologic Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Biologic Drugs Sales Volume Market Share by Application in 2016
Figure Japan Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Biologic Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Biologic Drugs Sales Volume (K Units) by Type (2012-2017)
Table Japan Biologic Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Biologic Drugs Sales Volume Market Share by Type in 2016
Table Japan Biologic Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Japan Biologic Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Biologic Drugs Sales Volume Market Share by Application in 2016
Figure South Korea Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Biologic Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Biologic Drugs Sales Volume (K Units) by Type (2012-2017)
Table South Korea Biologic Drugs Sales Volume Market Share by Type (2012-2017)
Figure South Korea Biologic Drugs Sales Volume Market Share by Type in 2016
Table South Korea Biologic Drugs Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Biologic Drugs Sales Volume Market Share by Application (2012-2017)
Figure South Korea Biologic Drugs Sales Volume Market Share by Application in 2016
Figure Taiwan Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Biologic Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Biologic Drugs Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Biologic Drugs Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Biologic Drugs Sales Volume Market Share by Type in 2016
Table Taiwan Biologic Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Biologic Drugs Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Biologic Drugs Sales Volume Market Share by Application in 2016
Figure India Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Biologic Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India Biologic Drugs Sales Volume (K Units) by Type (2012-2017)
Table India Biologic Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Biologic Drugs Sales Volume Market Share by Type in 2016
Table India Biologic Drugs Sales Volume (K Units) by Application (2012-2017)
Table India Biologic Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Biologic Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Biologic Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Biologic Drugs Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Biologic Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Biologic Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Biologic Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Biologic Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Biologic Drugs Sales Volume Market Share by Application in 2016
Figure Australia Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Biologic Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Biologic Drugs Sales Volume (K Units) by Type (2012-2017)
Table Australia Biologic Drugs Sales Volume Market Share by Type (2012-2017)
Figure Australia Biologic Drugs Sales Volume Market Share by Type in 2016
Table Australia Biologic Drugs Sales Volume (K Units) by Applications (2012-2017)
Table Australia Biologic Drugs Sales Volume Market Share by Application (2012-2017)
Figure Australia Biologic Drugs Sales Volume Market Share by Application in 2016
Table Roche Biologic Drugs Basic Information List
Table Roche Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Biologic Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Roche Biologic Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Abbott Laboratories Biologic Drugs Basic Information List
Table Abbott Laboratories Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Laboratories Biologic Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Abbott Laboratories Biologic Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson & Johnson Biologic Drugs Basic Information List
Table Johnson & Johnson Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Biologic Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Johnson & Johnson Biologic Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Merck & Co. Biologic Drugs Basic Information List
Table Merck & Co. Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co. Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Merck & Co. Biologic Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Merck & Co. Biologic Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer Biologic Drugs Basic Information List
Table Pfizer Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Biologic Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Biologic Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Amgen Biologic Drugs Basic Information List
Table Amgen Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Biologic Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Amgen Biologic Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi Biologic Drugs Basic Information List
Table Sanofi Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Biologic Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi Biologic Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis Biologic Drugs Basic Information List
Table Novartis Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Biologic Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis Biologic Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Eli Lilly Biologic Drugs Basic Information List
Table Eli Lilly Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly Biologic Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Eli Lilly Biologic Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Amgen Biologic Drugs Basic Information List
Table Amgen Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Biologic Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Amgen Biologic Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologic Drugs
Figure Manufacturing Process Analysis of Biologic Drugs
Figure Biologic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Biologic Drugs Major Manufacturers in 2016
Table Major Buyers of Biologic Drugs
Table Distributors/Traders List
Figure Asia-Pacific Biologic Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Biologic Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Biologic Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Biologic Drugs Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Biologic Drugs Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Biologic Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Biologic Drugs Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Biologic Drugs Revenue Market Share Forecast by Region in 2022
Figure China Biologic Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Biologic Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Biologic Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Biologic Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Biologic Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biologic Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Biologic Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Biologic Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Biologic Drugs Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Biologic Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Biologic Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Biologic Drugs Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Biologic Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Biologic Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other Sources), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)...

Executive Summary Azoth Analytics has released a research report titled "Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)" which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market segmentatio...

Global Antibiotic Drugs Market (2024 Edition): Analysis By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoroquinolone, Others), Spectrum (Broad, Narrow), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)...

Executive Summary Azoth Analytics has released a research report titled "Global Antibiotic Drugs Market (2024 Edition)" which provides a complete analysis of the global Antibiotic Drugs industry in terms of market segmentation By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoro...

Asia Pacific Cutting Tools Market 2023-2033 by Tool Type (Solid Round, Indexable), Product (Groovers, Reamers, Milling Cutters, Drills), Material (Cemented Carbide, HSS, Ceramics, CBN), Chip Breaker (Step, Ridge, Universal, Separate), Application, Industry Vertical, Distribution Channel (Offline, Online), and Country: Trend Forecast and Growth Opportunity...

Asia Pacific cutting tools market will grow by 6.0% annually with a total addressable market cap of $163.03 billion over 2024-2033. The growth is driven by the increasing production and manufacturing activities, improved operational efficiency and innovative design, and an increasing demand for powe...

Asia Pacific Paper Machine Clothing (PMC) Market 2023-2033 by Product Type (Forming Fabrics, Press Felts, Dryer Fabrics), Material (Nylon, Polyester, PVDF, Others), Application (Wrapping & Packaging Paper, Printing & Writing Paper, Household & Sanitary Paper, Newsprint, Others), and Country: Trend Forecast and Growth Opportunity...

Asia Pacific paper machine clothing (PMC) market will grow by 5.3% annually with a total addressable market cap of $7.27 billion over 2024-2033. The growth is driven by the increasing demand for paper and paper-based products across various industries, technological advancements in the papermaking p...

Asia Pacific Endoscopy Devices Market 2023-2033 by Device Type, Hygiene, Application, End User, and Country: Trend Forecast and Growth Opportunity...

Asia Pacific endoscopy devices market will grow by 7.7% annually with a total addressable market cap of $150.27 billion over 2024-2033. The growth is driven by the increasing prevalence of chronic diseases, the growing demand for less invasive procedures, a rising adoption of disposable endoscopic c...

Asia Pacific Digital Health and Wellness Market 2023-2033 by Product (Hardware, Solutions), Category (Health, Wellness), Connectivity (Cellular, NFC, Bluetooth, Wi-Fi), End User (Hospitals & Clinics, ASCs, Homecare & Individuals), Age Group (Pediatric, Adults, Geriatric), Distribution Channel (Online, Specialty Stores, Department Stores, Hypermarket), and Country: Trend Forecast and Growth Opportunity...

Asia Pacific digital health and wellness market will grow by 20.8% annually with a total addressable market cap of $3,072.0 billion over 2024-2033. The growth is driven by an increasing number of chronic diseases, the growing investment in health and wellness programs, the increased use of smartphon...

Asia Pacific Connected Healthcare Device Market 2023-2033 by Product (Medical Devices, Wellness Devices, Software & Services), Device Type (Wearable, Implantable, Stationary), Application (Remote Monitoring, Consultation and Diagnosis, Treatment, Fitness and Wellness), End User (Hospitals, Clinics, ASCs, Home Care), and Country: Trend Forecast and Growth Opportunity...

Asia Pacific connected healthcare device market will grow by 21.1% annually with a total addressable market cap of $495.3 billion over 2024-2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetrat...

Asia Pacific Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology...

Asia Pacific Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Country: Trend Forecast and Growth Opportunity...

Asia Pacific biopharmaceuticals market will grow by 10.3% annually with a total addressable market cap of $1,776.7 billion over 2024-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discove...

Asia Pacific Encoder Market 2023-2033 by Encoder Type (Rotary, Linear), Signal Type (Absolute, Incremental), Technology (Optical, Magnetic, Photoelectric, Inductive), Application (Automotive, Electronics, Industrial, Healthcare), and Country: Trend Forecast and Growth Opportunity...

Asia Pacific encoder market will grow by 10.6% annually with a total addressable market cap of $18.21 billion over 2024-2033. The growth is driven by the increased need for high-level automation across various industries, the surging demand for automobile and consumer electronics, and technological ...